Viewing Study NCT01103050


Ignite Creation Date: 2025-12-24 @ 5:21 PM
Ignite Modification Date: 2026-01-24 @ 3:46 AM
Study NCT ID: NCT01103050
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2010-04-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CQAV680A2204
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators